Information Library
High-quality studies - Central Lab
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
QUINTILES ADDS DIGITAL PATHOLOGY SERVICES
September 14, 2009 - Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announced today the availability of digital pathology services in Beijing, China. The services add to Quintiles offerings used in the development of therapies to treat the world’s most pressing health issues, including cancer. -
Validated Biomarker Menu
July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays. -
The Importance of Latin America
June 8, 2009
Video showing why Latin America’s a great option for Clinical trials. With a total population over 500 million people and only two major languages, you will find a world of opportunity in the region. -
India Today: Quintiles Central Laboratory
June 8, 2009
Video explaining why India’s a great option for clinical trials. Benefits include access to patients, potential cost savings, experienced investigators, and state of the art technology. -
India Rising: Quintiles Central Laboratory
June 8, 2009
Need content here -
QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS
May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments. -
QUINTILES CENTRAL LAB IN ARGENTINA RECEIVES CAP ACCREDIATION
March 11, 2009 - Quintiles Central Lab in Buenos Aires is latest facility to be accredited in the world’s largest CAP-accredited lab network.
Page 1 of 1 (7 items)